2006
- 2006/12/19
- Takara Bio Grants NEB a license for LA-PCR Technology
- 2006/01/29
- Supply of RetroNectin® to the Peter MacCallum Cancer Centre in Australia for gene therapy clinical trials of multiple myeloma
- 2006/09/21
- Takara Bio Announces PCR Technologies License Agreement
- 2006/09/06
- Supply of RetroNectin® to Memorial Sloan Kettering Cancer Center's gene therapy clinical study of chronic lymphocytic leukemia
- 2006/07/25
- Takara Bio (Shiga, Japan) announces that peripheral blood T cells expanded on immobilized RetroNectin® have enhanced cytotoxic activity against tumor cells over T cells expanded by conventional method
- 2006/07/06
- Takara Bio Grants exclusive worldwide (excluding Japan) license to InVivoScribe Technologies to use detection method of FLT3 mutation
- 2006/05/12
- Takara Bio Settles Patent Matter with Stratagene
- 2006/01/19
- US Court of Appeals for Federal Circuit remanded a patent lawsuit relating to Clontech's Reverse Transcriptase (RT) Product
